A Comparative study of Doxycycline and Zinc Sulfate with Doxycycline in the treatment of acne

A Comparative study of Doxycycline and Zinc Sulfate with Doxycycline in the treatment of acne vulgaris patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20100102002954N17

Enrollment

140

Registered

2019-09-20

Start date

2019-10-06

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne vulgaris. Acne vulgaris

Interventions

Intervention 1: Intervention group:: Using Doxycycline capsula (Pars darou Company) in a double dose (200 mg/day) orally for three months in addition using Zinc sulfat tablet (Alborz company) daily (

Eligibility

Sex/Gender

All

Age

15 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with voulgaris acne; Age range 15-50 years; Satisfaction with the research.

Exclusion criteria

Exclusion criteria: Previous burns; Severe hormonal disorders such as hypothyroidism; Chronic liver and kidney disease; Pregnancy and lactation; Doing restorative skin care like laser.

Design outcomes

Primary

Measure	Time frame
Acne healing speed. Timepoint: Once every two weeks. Method of measurement: Skin imaging and global response assessment.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Mohammad Bagher Sohrabi

Shahroud University of Medical Sciences

mb.sohrabi@shmu.ac.ir+98 23 3234 2000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026